United Kingdom · Series B startup

Who invested in Epsilogen Ltd.

One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$41Mraised across 1 round since 2022, from 17 sources

Latest round
Series B, $41MMar 2022
Led by
Novartis Venture Fund
Investors
7 (1 led)
See who backed them

The rounds

  1. Mar 2022
    Series B$41M

    Reported by UCL Technology Fund and 16 others

Funding filed with regulators

Epsilogen Ltd. filed 6 raises, $117M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Aug 2025$14MUK share allotment
  2. Mar 2025$37MUK share allotment
  3. Sept 2024$1.4MUK share allotment
  4. Aug 2024$35MUK share allotment
  5. Dec 2023$6.4MUK share allotment
  6. Feb 2022$23MUK share allotment

Founders and team

From Epsilogen Ltd.'s own website: 10 on the team.

  • Cristina OlivaChief Medical Officer
  • Elizabeth HardakerChief Translational Science Officer
  • Kevin FitzGeraldChief Scientific Officer
  • Nick Robbins-CherryChief Financial Officer
  • Leanne PartingtonVP of Product Development
  • Alek SafarianBoard Member
  • Marianne BjørdalBoard Member
  • Marianne UtengBoard Member
  • Pete FinanNon-Executive Chairman
  • Sonia GulatiBoard Member

AdvisersJosep Tabernero Clinical Advisor

Everyone who backed them

Novartis Venture FundCorporate VC1round, led 1
Epidarex CapitalVC firm1round
Schroders CapitalHedge fund1round
3B Future Health Fund I & IIVC firm1round
British Patient CapitalFund of funds1round
ALSA VenturesVC firm1round
Caribou PropertyGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Epsilogen Ltd.

Who invested in Epsilogen Ltd.?

Epsilogen Ltd.'s investors include Novartis Venture Fund, Epidarex Capital, Schroders Capital, 3B Future Health Fund I & II and British Patient Capital, and 2 more on record. Novartis Venture Fund led its latest round.

How much has Epsilogen Ltd. raised?

Epsilogen Ltd. has raised $41M across 1 round since 2022.

When did Epsilogen Ltd. last raise?

Epsilogen Ltd.'s most recent round was a Series B of $41M in Mar 2022, led by Novartis Venture Fund.

What was Epsilogen Ltd.'s biggest round?

Its most recent round, $41M in Mar 2022, is also its largest on record.

Who backed Epsilogen Ltd. first?

Epsilogen Ltd.'s first round on record, in Mar 2022, was backed by Novartis Venture Fund, Epidarex Capital and Schroders Capital and 4 others.

What stage is Epsilogen Ltd. at?

Epsilogen Ltd.'s latest named round is a Series B, in Mar 2022.

Where is Epsilogen Ltd. based?

Epsilogen Ltd. is based in the United Kingdom.

Who led Epsilogen Ltd.'s rounds?

Novartis Venture Fund led the Series B in 2022.

Companies like Epsilogen Ltd.

In the same sector, and raised in the last eighteen months.

Coherence Neuro$55M · Oct 2026HydRegen$12M · Oct 2026XRlabs$8.4M · Oct 2026OMass Therapeutics$442M · Oct 2026CMR Surgical$1.1B · Oct 2026MintNeuro$26M · Oct 2026

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app